EP0652888A4 - INHIBITION OF -i(CANDIDA). - Google Patents

INHIBITION OF -i(CANDIDA).

Info

Publication number: EP0652888A4
Authority: EP; European Patent Office
Prior art keywords: candida; inhibition
Prior art date: 1990-08-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19910916648

Other languages

German (de)

French (fr)

Other versions

EP0652888A1 (en

Inventor

Glenn D Hoke

David J Ecker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ionis Pharmaceuticals Inc

Original Assignee

Isis Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-16

Filing date

1991-08-15

Publication date

1993-09-23

1991-08-15 Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc

1993-09-23 Publication of EP0652888A4 publication Critical patent/EP0652888A4/en

1995-05-17 Publication of EP0652888A1 publication Critical patent/EP0652888A1/en

Status Withdrawn legal-status Critical Current

Links

241000222120 Candida <Saccharomycetales> Species 0.000 title 1
230000005764 inhibitory process Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Steroid Compounds (AREA)

EP91916648A 1990-08-16 1991-08-15 INHIBITION OF $i(CANDIDA) Withdrawn EP0652888A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56867290A	1990-08-16	1990-08-16
US568672		1990-08-16
PCT/US1991/005802 WO1992003455A1 (en)	1990-08-16	1991-08-15	INHIBITION OF $i(CANDIDA)

Publications (2)

Publication Number	Publication Date
EP0652888A4 true EP0652888A4 (en)	1993-09-23
EP0652888A1 EP0652888A1 (en)	1995-05-17

Family

ID=24272249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP91916648A Withdrawn EP0652888A1 (en)	1990-08-16	1991-08-15	INHIBITION OF $i(CANDIDA)

Country Status (6)

Country	Link
EP (1)	EP0652888A1 (en)
JP (1)	JPH0779704B2 (en)
AU (1)	AU649734B2 (en)
BR (1)	BR9106752A (en)
CA (1)	CA2089665A1 (en)
WO (1)	WO1992003455A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020055101A1 (en)	1995-09-11	2002-05-09	Michel G. Bergeron	Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
DE19654946A1 (en) *	1996-10-22	1998-05-07	Univ Eberhard Karls	Detecting fungi resistant to azole antimycotics in clinical samples
DE19643486C1 (en) *	1996-10-22	1998-12-03	Univ Eberhard Karls	Detection of resistant fungal cells in clinical material
FR2755145B1 (en) *	1996-10-28	1999-01-15	Gervais Danone Co	PROCESS FOR DEMONSTRATING LIVE MICROBIOLOGICAL CONTAMINANTS IN A SAMPLE OF A PRODUCT FOR FOOD USE
US20030049636A1 (en)	1999-05-03	2003-03-13	Bergeron Michel G.	Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en)	1997-11-04	2010-10-21	Bergeron Michel G	Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6096511A (en) *	1997-06-10	2000-08-01	Merck & Co., Inc.	Protein elongation factor 2 as a target for antifungal and antiparasitic agents
WO1998057176A1 (en) *	1997-06-10	1998-12-17	Merck & Co., Inc.	Protein elongation factor 2 as a target for antifungal and antiparasitic agents
GB9719044D0 (en) *	1997-09-08	1997-11-12	Inst Of Ophthalmology	Assay
EP1246935B1 (en)	1999-09-28	2013-08-14	Geneohm Sciences Canada Inc.	Highly conserved genes and their use to generate probes and primers for detection of microorganisms
KR100448877B1 (en) *	2002-08-19	2004-09-18	한국전력공사	Apparatus for reducing COD from flue-gas desulfurization waste by electrochemical oxidation process
US20040203006A1 (en) *	2003-04-11	2004-10-14	Cytokinetics, Inc.	Novel beta-tubulin protein of Candida glabrata and methods for its use
CN113508176A (en) *	2019-02-28	2021-10-15	米尼翁大学	Antisense oligomers for controlling candida albicans infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU659482B2 (en) *	1991-06-28	1995-05-18	Massachusetts Institute Of Technology	Localized oligonucleotide therapy
NZ244820A (en) *	1991-10-25	1994-01-26	Isis Pharmaceuticals Inc	Oligonucleotide inhibitor of epstein-barr virus.
GB9125891D0 (en) *	1991-12-05	1992-02-05	Inst Of Cancer The Research	Antiviral agent

1991
- 1991-08-15 WO PCT/US1991/005802 patent/WO1992003455A1/en not_active Ceased
- 1991-08-15 JP JP3515320A patent/JPH0779704B2/en not_active Expired - Lifetime
- 1991-08-15 AU AU86355/91A patent/AU649734B2/en not_active Ceased
- 1991-08-15 BR BR919106752A patent/BR9106752A/en not_active Application Discontinuation
- 1991-08-15 CA CA002089665A patent/CA2089665A1/en not_active Abandoned
- 1991-08-15 EP EP91916648A patent/EP0652888A1/en not_active Withdrawn

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GENE vol. 72, 1988, AMSTERDAM NL pages 311 - 312 JESSUS, C. ET AL. 'Specific inhibition of beta-tubulin synthesis in Xenopus oocytes using anti-sense oligodeoxyribonucleotides' *
JOURNAL OF BACTERIOLOGY vol. 172, no. 4, April 1990, AMERICAN SOCIETY FOR MICROBIOLOGY pages 2036 - 2045 SUNDSTROM P. ET AL. 'Sequence analysis and expression of the two genes for elongation factor 1alpha from the dimorphic yeast Candida albicans' *
NUCLEIC ACIDS RESEARCH vol. 15, no. 14, 24 July 1987, ARLINGTON, VIRGINIA US pages 5749 - 5763 MARCUS-SEKURA, C. ET AL. 'Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages' *
See also references of WO9203455A1 *

Also Published As

Publication number	Publication date
WO1992003455A1 (en)	1992-03-05
JPH06501844A (en)	1994-03-03
AU8635591A (en)	1992-03-17
EP0652888A1 (en)	1995-05-17
BR9106752A (en)	1993-08-17
AU649734B2 (en)	1994-06-02
CA2089665A1 (en)	1992-02-17
JPH0779704B2 (en)	1995-08-30

Legal Events

Date	Code	Title	Description
1995-03-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-05-17	17P	Request for examination filed	Effective date: 19930312
1995-05-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE
1996-07-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1996-08-28	18D	Application deemed to be withdrawn	Effective date: 19960301

Publication	Publication Date	Title
AR244753A1 (en)	1993-11-30	Azo-colouring.
DE69014117D1 (en)	1994-12-15	Radiotherapiesystem.
EP0597463A3 (en)	1996-11-06	Thermotherapiesonde.
EP0593428A4 (en)	1992-09-01	Myconematicide.
DE69000624D1 (en)	1993-02-04	Schliessmechanismus.
EP0580285A3 (en)	1995-05-03	Auto-reclosers.
DE69012800D1 (en)	1994-10-27	Hüftprothese.
DE69000353D1 (en)	1992-11-05	Fluegelzellenmaschine.
ZA919660B (en)	1993-06-07	Alpha-oxoacetamide derivatives.
DE69001591D1 (en)	1993-06-17	Tuerschliesser.
DE69111595D1 (en)	1995-08-31	Squarylium- und crokonyliumfarbstoffe.
DE69104185D1 (en)	1994-10-27	Luftreservoir.
DE69112211D1 (en)	1995-09-21	Luftreinigungsvorrichtung.
PH30977A (en)	1997-12-23	Hiv-inhibiting benzene-acetamide derivatives.
DE68907587D1 (en)	1993-08-19	Trappingssystem.
DE59204008D1 (en)	1995-11-16	Trachealstent.
DE69106281D1 (en)	1995-02-09	Phenanthrenderivat.
EP0652888A4 (en)	1993-09-23	INHIBITION OF -i(CANDIDA).
DE69022965D1 (en)	1995-11-16	Aminopiperazinderivate.
DE59008181D1 (en)	1995-02-16	Trifluormethylcyclohexan-derivate.
DE59006531D1 (en)	1994-08-25	Interferometeranordnung.
DE69002778D1 (en)	1993-09-23	Pyrolytisches bornitrid.
ZA904897B (en)	1991-03-27	Vip-analogs ii.
DE59001720D1 (en)	1993-07-15	Spruehvorrichtung.
DE59000988D1 (en)	1993-04-08	Brueckenuntersichtvorrichtung.